ADMA Biologics
ADMA
24 hedge funds and large institutions have $59.2M invested in ADMA Biologics in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
0% more funds holding
Funds holding: 24 → 24 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
9% less capital invested
Capital invested by funds: $65.4M → $59.2M (-$6.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$591K |
| 2 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$361K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$169K |
| 4 |
CCM
Consonance Capital Management
New York
|
+$161K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$863K |
| 2 |
TI
Telemetry Investments
New York
|
-$313K |
| 3 |
SIM
Spark Investment Management
New York
|
-$103K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$10.2K |
ADMA Hedge Fund Activity: Q3 2015 in Review
24 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q3 2015, worth a combined $59.2M — down 9.4% from $65.4M a quarter earlier.
Fund positioning in ADMA was balanced in Q3 2015: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 3 trimmed.
The largest buyer was Weiss Multi-Strategy Advisers, adding an estimated $591K. The largest seller was Franklin Resources, cutting an estimated $863K.
- 24 institutional investors held ADMA Biologics (ADMA) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $59.2M of ADMA Biologics stock for Q3 2015, down 9.4% quarter-over-quarter.
- 4 funds opened new ADMA Biologics positions in Q3 2015 and 4 closed out, a net change of 0 holders.
- The largest ADMA Biologics buyer in Q3 2015 was Weiss Multi-Strategy Advisers, an estimated $591K added.
- The largest ADMA Biologics seller in Q3 2015 was Franklin Resources, an estimated $863K sold.
Based on aggregated 13F filings for Q3 2015.